We create innovation for the health and wellness of all human kind.
We manufacture a wide variety of off-patent generic drugs to provide accessibility for everyone. Our goal is to be first to file in many areas and with over a 500+ dosage formulations. We cover major finished formulations and therapeutic categories including oncology, CNS, cardiovascular, and many others for out-licensing in ROW and developed markets.
Our Life Sciences group is on the cutting-edge of investments in novel therapeutics. We are changing the way sovereign nations look at wellness and longevity. Our investments in high value molecules includes biologics, biosimilars, rare disease, 505B2s, vaccines and orphan drugs. We fund clinical trials, IP development and advanced therapeutics including CARTs, MABs, ADC’s for oncology, anti-aging, immunology and other life enhancing indications.
LODAAT is the leader for science based structural, functional ingredients for the food, beverage, nutraceutical and pharmaceutical industries. Our premium branded ingredients are supported by patented manufacturing processes; the highest quality; regulatory support; double-blinded placebo control studies, and peer reviewed publications. Major therapeutic categories include gut microbiome, sports nutrition, sleep, mood, women’s health, and bone-joint support.
LODAAT manufactures a full range of finished formulations of nutraceutical and OTC products in our USA facilities. We have full tablet & capsule capabilities and our products come with DMF & dossiers for regulated and global markets.
Our formulations support major health indications including energy, weight management, sleep, and pain.
LODAAT, or "Live One Day at a Time" is an American science-driven firm that was founded in 2007. Our mandate is to produce the world's best novel therapeutics, innovative high-value molecules, and clinically studied ingredients for the pharmaceutical, nutraceutical, and food & beverage industries. Our quest to research and fund health & wellness therapeutics has resulted in unique formulations, patented manufacturing processes, and proprietary programs.
We are an innovation-based pharmaceuticals firm. The paradigm shift of implementing US technology with leading global partners in a scientific methodology has been the inspiration behind LODAAT.
LODAAT partners with a variety of leading firms in developed and global markets. From sovereign wealth funds, private equity
firms, privately held conglomerates, and publicly traded multinationals, our partners are reputable global leaders.
